Skip to main content
An official website of the United States government
Email

Barrett's Esophagus Translational Research Network (BETRNet)

Esophageal Adenocarcinoma Stage IIA
Credit: © Terese Winslow

The Barrett’s Esophagus Translational Research Network (BETRNet) is a program (supported by DCB and the NCI Division of Cancer Prevention through RFA-CA-16-006/RFA-CA-16-007) that was established to address the rising incidence of esophageal adenocarcinoma in the United States. 

BETRNet objectives are to achieve a better understanding of esophageal adenocarcinoma biology, examine research opportunities associated with its precursor lesion Barrett’s Esophagus, and improve prevention of esophageal cancers.

BETRNet Patient Registry with Virtual Biorepository

BETRNet created a catalog of Barrett’s esophagus and esophageal adenocarcinoma bio-specimens available for research purposes. Additional information can be found at the Biorepository website.

BETRNet Digital Media

Additional information about the program can be found at websites created by BETRNet centers:

DCB Contact for BETRNet

For additional information about BETRNet, please contact Dr. Rihab Yassin.

Funded Projects

Institution Principal Investigator(s) Project Title

Case Western Reserve University

Amitabh Chak, Kishore Guda

Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

University of Michigan

Thomas D. Wang, Joel H. Rubenstein

Early Targets in Progression of Barrett's Esophagus to Esophageal Adenocarcinoma

Vanderbilt University Medical Center

Yu Shyr

Barrett's Esophagus Translational Research Network Coordinating Center (BETRNetCC)

Past Projects

Institution Principal Investigator(s) Project Title

Columbia University Health Sciences

Julian Abrams, Anil K. Rustgi, Kenneth K. Wang

The Role of the Microenvironment in Barrett's Esophagus

University of Michigan

Thomas D. Wang, Joel H. Rubenstein

Early Targets in Progression of Barrett's Esophagus to Esophageal Adenocarcinoma

  • Posted:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Barrett's Esophagus Translational Research Network (BETRNet) was originally published by the National Cancer Institute.”

Email